• Team
  • Banking
  • Dan Berenson

Dan Berenson

Senior Managing Director, Healthcare Mergers & Acquisitions

Dan Berenson is a Senior Managing Director focused at Leerink Partners focused on Biopharma Mergers & Acquisitions.

Prior to joining the Firm in 2019, Dan spent the early part of his career at Centerview Partners and Guggenheim Securities where he executed multiple biopharma transactions. Dan has extensive experience advising both public and private biopharma companies on matters involving mergers and acquisitions, asset sales and licensing transactions. During his 15 years as a healthcare M&A professional, he has advised on >30 strategic transactions, including Assertio’s acquisition of Spectrum Pharmaceuticals, Rocket Pharmaceuticals’ acquisition of Renovacor, Zogenix’s sale to UCB, Dermira’s sale to Eli Lilly and Ambit’s sale to Daiichi Sankyo.

He earned an M.B.A. from Yale School of Management and a B.A. from Emory College.

Banner desktop

Partner With Us

Let us help you achieve your strategic,
capital markets, and investment objectives

Contact Us

Our experienced team is happy to assist you. Please complete the form below and we’ll be in touch as soon as possible. *” indicates required fields

This field is for validation purposes and should be left unchanged.